Obstructive sleep apnea: The new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease

Heart Failure Reviews

Volumn 14, Issue 3, 2009, Pages 143-153

  Khayat, Rami ^a   Patt, Brian ^a   Hayes Jr , Don ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Endothelial dysfunction; Heart failure; Intermittent hypoxia; Obstructive sleep apnea; Oxidative stress

Indexed keywords

3 NITROTYROSINE; ASCORBIC ACID; C REACTIVE PROTEIN; CD15 ANTIGEN; CYTOCHROME P450; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOPROTEIN P 15095; GRANULOCYTE CHEMOTACTIC PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; PADGEM PROTEIN; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TETRAHYDROBIOPTERIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOREDOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HUMAN; HYPERTENSION; HYPOXIA; INFLAMMATION; LIPID PEROXIDATION; LUNG EDEMA; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME; SYMPATHETIC TONE; ANOXIA; CARDIOVASCULAR DISEASES; COMPLICATION; PATHOPHYSIOLOGY; RISK FACTOR; SLEEP DISORDERED BREATHING; TIME; VASCULAR ENDOTHELIUM;

ANOXIA; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HEART FAILURE; HUMANS; INFLAMMATION; OXIDATIVE STRESS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS;

EID: 67649366023     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-008-9112-z     Document Type: Review

References (143)

1. Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. J Am Med Assoc 291(16):2013-2016. doi: 10.1001/ jama.291.16.2013
2. Young T et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230-1235. doi: 10.1056/ NEJM199304293281704
3. McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156-178. doi: 10.1183/ 09031936.00027406
4. Campos-Rodriguez F et al (2005) Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128(2):624-633. doi: 10.1378/chest.128.2.624
5. Doherty LS et al (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127(6):2076-2084. doi: 10.1378/chest.127.6.2076
6. Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 365(9464):1046-1053
7. Badr MS (1996) Effect of ventilatory drive on upper airway patency in humans during NREM sleep. Respir Physiol 103(1):1-10. doi: 10.1016/ 0034-5687(95)00079-8
8. Jordan AS, White DP (2008) Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir Physiol Neurobiol 160(1):1-7. doi: 10.1016/j.resp.2007.07.009
9. Malhotra A et al (2001) Upper-airway collapsibility: Measurements and sleep effects. Chest 120(1):156-161. doi: 10.1378/chest.120.1.156
10. Horner RL et al (1989) Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 2(7):613-622
11. Morgan BJ, Denahan T, Ebert TJ (1993) Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 74(6):2969-2975
12. Katragadda S et al (1997) Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J Appl Physiol 83(6):2048-2054
13. Peng YJ, Prabhakar NR (2003) Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J Appl Physiol 94(6):2342-2349
14. Prabhakar NR et al (2001) Intermittent hypoxia: Cell to system. Am J Physiol Lung Cell Mol Physiol 281(3):L524-L528
15. Prabhakar NR, Kline DD (2002) Ventilatory changes during intermittent hypoxia: Importance of pattern and duration. High Al Med Biol 3(2):195-204. doi: 10.1089/15270290260131920
16. Cutler MJ et al (2004) Periods of intermittent hypoxic apnea can alter chemoreflex control of sympathetic nerve activity in humans. Am J Physiol Heart Circ Physiol 287(5):H2054-H2060. doi: 10.1152/ ajpheart.00377.2004
17. Lesske J et al (1997) Hypertension caused by chronic intermittent hypoxia-influence of chemoreceptors and sympathetic nervous system. J Hypertens 15(12 Pt 2):1593-1603
18. Fletcher EC (2001) Invited review: Physiological consequences of intermittent hypoxia: Systemic blood pressure. J Appl Physiol 90(4):1600-1605
19. Brooks D et al (1997) Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99(1):106-109. doi: 10.1172/JCI119120
20. Somers VK et al (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897-1904. doi: 10.1172/JCI118235
21. Xie A et al (2000) Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 89(4):1333-1339
22. Cutler MJ et al (2004) Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol 96(2):754-761. doi: 10.1152/japplphysiol.00506.2003
23. Xie A et al (2001) Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91(4):1555-1562
24. Khayat RN et al (2004) Role of sensory input from the lungs in control of muscle sympathetic nerve activity during and after apnea in humans. J Appl Physiol 97(2):635-640. doi: 10.1152/japplphysiol.00241.2004
25. Prabhakar NR et al (2005) Cardiovascular alterations by chronic intermittent hypoxia: Importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 32(5-6):447-449. doi: 10.1111/j.1440-1681.2005.04209.x
26. Fletcher EC et al (1992) Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 72(5):1978-1984
27. Fletcher EC et al (1992) Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19(6 Pt 1):555-561
28. Fletcher EC et al (1992) Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20(5):612-619
29. Bao G et al (1997) Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83(1):95-101
30. Dick TE et al (2007) Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp Physiol 92(1):87-97. doi: 10.1113/expphysiol.2006.035758
31. Sica AL et al (2000) Chronic-intermittent hypoxia: A model of sympathetic activation in the rat. Respir Physiol 121(2-3):173-184. doi: 10.1016/S0034-5687(00)00126-2
32. Greenberg HE et al (1999) Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 86(1):298-305
33. Fletcher EC (2003) Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 26(1):15-19
34. Julius S, Esler MD, Randall OS (1975) Role of the autonomic nervous system in mild human hypertension. Clin Sci Mol Med Suppl 2:243s-252s
35. Esler M et al (1986) Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 8(Suppl 5):S39-S43
36. Esler M et al (1976) High-renin essential hypertension: Adrenergic cardiovascular correlates. Clin Sci Mol Med Suppl 3:181s-184s
37. Oparil S, Zaman MA, Calhoun DA (2003) Pathogenesis of hypertension. Ann Intern Med 139(9):761-776
38. Guo GB, Abboud FM (1984) Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 246(1 Pt 2):H80-H89
39. Rumantir MS et al (2000) The "adrenaline hypothesis" of hypertension revisited: Evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens 18(6):717-723. doi: 10.1097/00004872-200018060-00009
40. Kim JR et al (1999) Heart rate and subsequent blood pressure in young adults: The CARDIA study. Hypertension 33(2):640-646
41. Farsang C et al (1981) Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension. Cardiology 67(3):164-171
42. Winternitz SR, Katholi RE, Oparil S (1980) Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest 66(5):971-978. doi: 10.1172/JCI109966
43. Ma X et al (2006) Dual mechanisms of angiotensin-induced activation of mouse sympathetic neurones. J Physiol 573(Pt 1):45-63. doi: 10.1113/ jphysiol.2006.106716
44. Ma X, Abboud FM, Chapleau MW (2001) A novel effect of angiotensin on renal sympathetic nerve activity in mice. J Hypertens 19(3 Pt 2):609-618. doi: 10.1097/00004872-200103001-00014
45. Ma X et al (2001) Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice. Circ Res 88(8):787-793. doi: 10.1161/hh0801.089542
46. Fletcher EC, Bao G, Li R (1999) Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34(2):309-314
47. Fletcher EC, Orolinova N, Bader M (2002) Blood pressure response to chronic episodic hypoxia: The renin-angiotensin system. J Appl Physiol 92(2):627-633
48. Somers VK, Mark AL, Abboud FM (1991) Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 87(6):1953-1957. doi: 10.1172/JCI115221
49. Chapleau MW, Hajduczok G, Abboud FM (1988) Mechanisms of resetting of arterial baroreceptors: An overview. Am J Med Sci 295(4):327-334. doi: 10.1097/00000441-198804000-00019
50. Cooper VL et al (2007) Daytime variability of baroreflex function in patients with obstructive sleep apnoea: Implications for hypertension. Exp Physiol 92(2):391-398. doi: 10.1113/expphysiol.2006.035584
51. Brooks D et al (1999) Baroreflex control of heart rate in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med 159(4 Pt 1):1293-1297
52. Li Z et al (1996) Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res 79(4):802-811
53. Peng YJ et al (2003) Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: Implications for recurrent apneas. Proc Natl Acad Sci USA 100(17):10073-10078. doi: 10.1073/pnas.1734109100
54. Rouwet EV et al (2002) Hypoxia induces aortic hypertrophic growth, left ventricular dysfunction, and sympathetic hyperinnervation of peripheral arteries in the chick embryo. Circulation 105(23):2791-2796. doi: 10.1161/01.CIR.0000017497.47084.06
55. Phillips SA et al (2006) Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. J Appl Physiol 100(4):1117-1123. doi: 10.1152/japplphysiol.00994.2005
56. Phillips SA et al (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286(1):H388-H393. doi: 10.1152/ajpheart.00683.2003
57. Allahdadi KJ, Walker BR, Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45(4):705-709. doi: 10.1161/01.HYP.0000153794.52852.04
58. Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37(2 Part 2):511-515
59. Sforza E et al (1996) Role of chemosensitivity in intrathoracic pressure changes during obstructive sleep apnea. Am J Respir Crit Care Med 154(6 Pt 1):1741-1747
60. Chen L, Scharf SM (1997) Comparative hemodynamic effects of periodic obstructive and simulated central apneas in sedated pigs. J Appl Physiol 83(2):485-494
61. Chen L, Shi Q, Scharf SM (2000) Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 88(3):1051-1060
62. Hall MJ et al (1998) Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol 85(4):1476-1484
63. Fletcher EC et al (1999) Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med 160((5 Pt 1)):1688-1696
64. Bradley TD, Floras JS (2003) Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 107(12):1671-1678. doi: 10.1161/ 01.CIR.0000061757.12581.15
65. Naughton MT (1998) Impact of treatment of sleep apnoea on left ventricular function in congestive heart failure. Thorax 53(Suppl 3):S37-S40
66. Tkacova R et al (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98(21):2269-2275
67. Koller A, Huang A (1994) Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res 74(3):416-421
68. Brevetti G et al (2003) Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108(17):2093-2098. doi: 10.1161/01.CIR.0000095273.92468.D9
69. Ross R (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362(6423):801-809. doi: 10.1038/362801a0
70. Juonala M et al (2007) Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circulation 116(12):1367-1373. doi: 10.1161/ CIRCULATIONAHA.107.690016
71. Ungvari Z et al (2002) Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: Morphological and functional evidence for increased peroxynitrite formation. Am J Pathol 161(1):145-153
72. Corretti MC et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257-265. doi: 10.1016/S0735-1097(01)01746-6
73. Kato M et al (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102(21):2607-2610
74. Ip MS et al (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169(3):348-353. doi: 10.1164/rccm.200306-767OC
75. Nieto FJ et al (2004) Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169(3):354-360. doi: 10.1164/rccm.200306-756OC
76. Tahawi Z et al (2001) Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 90(5):2007-2013, discussion 2000
77. Ip MS et al (2000) Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162(6):2166-2171
78. Geny B et al (2006) Comments on point-counterpoint "flow-mediated dilation does/does not reflect nitric oxide-mediated endothelial function". J Appl Physiol 100(1):362. doi: 10.1152/ japplphysiol.01313.2005
79. Wolin MS et al (1998) Oxidant-nitric oxide signalling mechanisms in vascular tissue. Biochemistry. Biokhimiia 63(7):810-816
80. Ogita H, Liao J (2004) Endothelial function and oxidative stress. Endothelium 11(2):123-132. doi: 10.1080/10623320490482664
81. Touyz RM, Schiffrin EL (2004) Reactive oxygen species in vascular biology: Implications in hypertension. Histochem Cell Biol 122(4):339-352. doi: 10.1007/s00418-004-0696-7
82. Grebe M et al (2006) Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173(8):897-901. doi: 10.1164/rccm.200508-1223OC
83. El Solh AA et al (2006) Allopurinol improves endothelial function in sleep apnoea: A randomised controlled study. Eur Respir J 27(5):997-1002
84. Pieper GM, Dembny K, Siebeneich W (1998) Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction. Diabetologia 41(10):1220-1226. doi: 10.1007/ s001250051055
85. Katayama Y et al (2004) Oral vitamin C ameliorates smoking-induced arterial wall stiffness in healthy volunteers. J Atheroscler Thromb 11(6):354-357
86. Svatikova A et al (2004) Circulating free nitrotyrosine in obstructive sleep apnea. Am J Physiol Regul Integr Comp Physiol 287(2):R284-R287. doi: 10.1152/ajpregu.00241.2004
87. Cosentino F et al (2008) Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart (British Cardiac Society) 94(4):487-492. doi: 10.1136/hrt.2007.122184
88. Channon KM (2004) Tetrahydrobiopterin: Regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 14(8):323-327. doi: 10.1016/j.tcm.2004.10.003
89. Stroes E et al (1997) Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99(1):41-46. doi: 10.1172/ JCI119131
90. Heller R et al (1999) L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274(12):8254-8260. doi: 10.1074/ jbc.274.12.8254
91. Zweier JL et al (1994) Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am J Physiol 266(3 Pt 1):C700-C708
92. Zweier JL (1998) Free radical generation in human endothelial cells exposed to anoxia and reoxygenation. Transplant Proc 30(8):4228-4232. doi: 10.1016/S0041-1345(98)01399-2
93. Houston M et al (1999) Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 274(8):4985-4994. doi: 10.1074/ jbc.274.8.4985
94. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91(6):2546-2551. doi: 10.1172/JCI116491
95. Mervaala EM et al (2001) Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension 37(2 Part 2):414-418
96. Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications. J Physiol 555(Pt 3):589-606. doi: 10.1113/jphysiol.2003.055913
97. Butler R et al (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35(3):746-751
98. Farquharson CA et al (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106(2):221-226. doi: 10.1161/ 01.CIR.0000022140.61460.1D
99. Guthikonda S et al (2004) Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers. Am J Cardiol 93(5):664-668. doi: 10.1016/j.amjcard.2003.11.046
100. Ohike Y et al (2005) Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 69(2):221-226. doi: 10.1253/circj.69.221
101. Suzuki YJ et al (2006) Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40(10):1683-1692. doi: 10.1016/j.freeradbiomed.2006.01.008
102. Svatikova A et al (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26(22):2435-2439. doi: 10.1093/eurheartj/ehi440
103. Wali SO et al (1998) Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 21(3):290-296
104. Ozturk L et al (2003) Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta 332(1-2):83-88. doi: 10.1016/S0009-8981(03)00126-8
105. Alzoghaibi MA, Bahammam AS (2005) Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: A pilot study. Sleep Breath 9(3):119-126. doi: 10.1007/ s11325-005-0022-1
106. Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27(1):123-128
107. Barcelo A et al (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16(4):644-647. doi: 10.1034/ j.1399-3003.2000.16d13.x
108. Christou K et al (2003) Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7(3):105-110. doi: 10.1007/s11325-003-0105-9
109. Christou K et al (2003) Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4(3):225-228. doi: 10.1016/S1389-9457(02)00253-8
110. Christou K et al (2008) Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med (in press). doi: 10.1016/ j.sleep.2007.10.011
111. Carpagnano GE et al (2002) Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 122(4):1162-1167. doi: 10.1378/chest.122.4.1162
112. Carpagnano GE et al (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124(4):1386-1392. doi: 10.1378/chest.124.4.1386
113. Tangirala RK et al (2001) Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 276(1):261-266. doi: 10.1074/jbc.M003324200
114. Pratico D (1999) F(2)-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 147(1):1-10. doi: 10.1016/S0021-9150(99)00257-9
115. Pratico D et al (1997) Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 100(8):2028-2034. doi: 10.1172/ JCI119735
116. Tan KC et al (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184(2):377-382. doi: 10.1016/ j.atherosclerosis.2005.04.024
117. Yamauchi M et al (2005) Oxidative stress in obstructive sleep apnea. Chest 127(5):1674-1679. doi: 10.1378/chest.127.5.1674
118. Park AM, Suzuki YJ (2007) Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. J Appl Physiol 102(5):1806-1814. doi: 10.1152/japplphysiol.01291.2006
119. Takahashi K et al (2008) Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal 10(4):715-726. doi: 10.1089/ars.2007.1949
120. Barcelo A et al (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27(4):756-760. doi: 10.1183/09031936.06.00067605
121. Teramoto S et al (2007) Improvement of endothelial function with allopurinol may occur in selected patients with OSA: Effect of age and sex. Eur Respir J 29(1):216-217, author reply 217-218. doi: 10.1183/ 09031936.00104806
122. Veasey SC et al (2004) Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27(2):194-201
123. Xu W et al (2004) Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126(2):313-323. doi: 10.1016/ j.neuroscience.2004.03.055
124. Schulz R et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162(2 Pt 1):566-570
125. Row BW et al (2004) Platelet-activating factor receptor-deficient mice are protected from experimental sleep apnea-induced learning deficits. J Neurochem 89(1):189-196. doi: 10.1111/j.1471-4159.2004.02352.x
126. Troncoso Brindeiro CM et al (2007) Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293(5):H2971-H2976. doi: 10.1152/ajpheart.00219.2007
127. Htoo AK et al (2006) Activation of nuclear factor kappaB in obstructive sleep apnea: A pathway leading to systemic inflammation. Sleep Breath 10(1):43-50. doi: 10.1007/s11325-005-0046-6
128. Nacher M et al (2007) Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155(1):93-96. doi: 10.1016/j.resp.2006.06.004
129. Vgontzas AN et al (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 82(5):1313-1316. doi: 10.1210/jc.82.5.1313
130. Kataoka T et al (2004) The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels. Tohoku J Exp Med 204(4):267-272. doi: 10.1620/tjem.204.267
131. Punjabi NM et al (2007) Elevated levels of neopterin in sleep-disordered breathing. Chest 132(4):1124-1130. doi: 10.1378/chest.07-0743
132. Yudkin JS et al (2000) Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148(2):209-214. doi: 10.1016/S0021-9150(99)00463-3
133. Ridker PM et al (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101(15):1767-1772
134. Lindmark E et al (2001) Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. J Am Med Assoc 286(17):2107-2113. doi: 10.1001/jama.286.17.2107
135. Haverkate F et al (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349(9050):462-466. doi: 10.1016/S0140-6736(96)07591-5
136. Lindahl B et al (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. New Engl J Med 343(16):1139-1147. doi: 10.1056/ NEJM200010193431602
137. Burke AP et al (2002) Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation 105(17):2019-2023. doi: 10.1161/ 01.CIR.0000015507.29953.38
138. Shamsuzzaman AS et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462-2464. doi: 10.1161/01.CIR.0000018948.95175.03
139. Larkin EK et al (2005) Variation of C-reactive protein levels in adolescents: Association with sleep-disordered breathing and sleep duration. Circulation 111(15):1978-1984. doi: 10.1161/ 01.CIR.0000161819.76138.5E
140. Yokoe T et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129-1134. doi: 10.1161/01.CIR.0000052627.99976.18
141. Lefer AM (1999) Role of the beta2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion. Ann Thorac Surg 68(5):1920-1923. doi: 10.1016/S0003-4975(99)01017-6
142. Minoguchi K et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):625-630. doi: 10.1164/rccm.200412-1652OC
143. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165(7):934-939